Maggie D. Flores, P.C.

Kirkland & Ellis is advising Patient Square, a dedicated health investment firm, on the $4.1 billion acquisition of Patterson Companies, Inc. (Nasdaq: PDCO), a leading dental and animal health distributor. A definitive agreement was announced December 11, 2024, and the transaction is expected to close in the fourth quarter of Patterson’s fiscal 2025, subject to the receipt of shareholder approval, regulatory approvals and customary closing conditions. Under the terms of the agreement, Patterson shareholders will receive $31.35 in cash per share, representing an approximately 49% premium to Patterson’s 30 calendar day volume-weighted average price ending December 4, 2024 (the last trading day prior to Patterson announcing the evaluation of strategic alternatives). Read the transaction press release The Kirkland team included corporate lawyers Maggie Flores, Michael Weisser and Oliver Yee; debt finance lawyers John Ilardo, Jason Kanner and Joel Weinberger; capital markets lawyers Julia Danforth and Sophia Hudson; and tax lawyer Mark Schwed.

Dec 11

1 min

Kirkland & Ellis counseled TPG Growth, a leading global alternative asset management firm, on its definitive agreement to sell an operator of private luxury terminals, PS (formerly known as The Private Suite) to Groupe ADP, an international airport operator. The transaction is subject to regulatory approvals and other customary closing conditions. Terms of the transaction were not disclosed. The transaction was announced August 22, 2024. Read TPG’s press release The Kirkland team was led by corporate partners Maggie Flores and Michael Chung and associate Max Eichner; and tax partners Jared Rusman and Bill Dong.

Aug 22

1 min

Kirkland & Ellis is advising Jared Isaacman, the founder of Shift4 Payments, Inc. (NYSE: FOUR) in connection with the simplification of Shift4’s corporate structure, which was previously announced as being negotiated. The simplification transaction collapsed the company’s multi-share class structure into a single Class A share class structure and resulted in Isaacman assigning and waiving his rights under a tax receivable agreement with the company. This transaction was entered into in connection with Mr. Isaacman’s appointment as the Administrator of the National Aeronautics and Space Administration (NASA) and eliminated the company's previous "controlled company" status under NYSE corporate governance standards. In connection with the transaction, Mr. Isaacman received aggregate value of $191.8 million from the company, consisting of a combination of cash, newly issued shares of mandatory convertible preferred stock and the deemed satisfaction of certain obligations for Mr. Isaacman to fund a portion of the company’s equity award program. Mr. Isaacman remains the company's largest equity holder with an approximately 25.9% ownership, following more than 25 years of founding, leading and growing the business into a global financial technology powerhouse. Read the transaction press release The Kirkland team included corporate lawyers Jonathan Davis and Maggie Flores; litigation lawyers Reg Brown and Ridge Blanchard; tax lawyers Sehj Vather, Dean Shulman and David Foster; debt finance lawyer Patrick Loughery; and capital markets lawyer Leia Andrew.

Feb 9

1 min

Kirkland & Ellis advised global alternative asset management firm TPG on a majority investment in Surescripts, the nation’s leading health information network. The transaction was announced October 1, 2024. TPG is investing in Surescripts through TPG Capital, the firm’s U.S. and European private equity platform. The investment will allow Surescripts to develop an array of solutions addressing healthcare’s biggest challenges and accelerate Surescripts’ ability to scale existing Intelligent Prescribing, Benefits and Authorizations, and Clinical Interoperability solutions. The transaction is subject to customary regulatory approvals. Read the transaction press release The Kirkland team was led by corporate partners Michael Weisser, Maggie Flores and Zach Miller; antitrust & competition partner Matt Reilly; tax partners Jared Rusman and Bill Dong; executive compensation partners Stephen Jacobson and Alison Beskin; and technology & IP transactions partners Seth Traxler and Shellie Freedman.

Oct 2

1 min

Kirkland & Ellis advised Patient Square Capital on the sale of its remaining interest in Radius Health to B‑FLEXION Life Sciences. Patient Square and B-FLEXION originally acquired Radius in August 2022 through a take‑private transaction. The transaction was announced January 12, 2026 and is expected to close by the end of the first quarter of 2026. Read the transaction press release The Kirkland team included corporate lawyers Maggie Flores, Michael Weisser and Zach Miller; and tax lawyer Mark Schwed.

Jan 14

1 min